Literature DB >> 25696076

Angiographic determination of myocardial reperfusion by primary coronary angioplasty for acute myocardial infarction.

F Zijlstra, A W J van 't Hof, H Suryapranata, J C A Hoorntje, M J de Boer.   

Abstract

BACKGROUND: The primary objective of reperfusion therapies for acute myocardial infarction is not only restoration of blood flow in the epicardial coronary artery but also complete and sustained reperfusion of the infarcted part of the myocardium.
METHODS: We studied 777 patients who underwent primary coronary angioplasty during a six-year period and investigated the value of angiographic evidence of myocardial reperfusion (myocardial blush grade) in relation to the extent of ST-segment elevation resolution, enzymatic infarct size, left ventricular function, and long-term mortality. The myocardial blush immediately after the angioplasty procedure was graded by two experienced investigators, who were otherwise blinded to all clinical data: 0: no myocardial blush, 1: minimal myocardial blush, 2: moderate myocardial blush, and 3: normal myocardial blush.
RESULTS: The myocardial blush was related to the extent of the early ST-segment elevation resolution on the 12-lead electrocardiogram. Patients with blush grades 3, 2 and 0/1 had enzymatic infarct sizes of 757, 1143 and 1623 (p<0.0001), respectively, and ejection fractions of 0.50, 0.46 and 0.39, respectively (p<0.0001). After a mean±SD follow-up of 1.9±1.7 years, mortality rates of patients with myocardial blush grades 3, 2 and 0/1 were 3%, 6% and 23% (p<0.0001), respectively. Multivariate analysis showed that the myocardial blush grade was a predictor of long-term mortality, independent of Killip class, Thrombolysis In Myocardial Infarction (TIMI) grade flow, left ventricular ejection fraction, and other clinical variables.
CONCLUSION: In patients after reperfusion therapy, the myocardial blush grade as seen on the coronary angiogram can be used to describe the effectiveness of myocardial reperfusion, and is an independent predictor of long-term mortality.

Entities:  

Keywords:  acute myocardial infarction; coronary angiography; reperfusion therapy

Year:  2002        PMID: 25696076      PMCID: PMC2499706     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  22 in total

1.  Effect of thrombolytic treatment delay on myocardial infarct size.

Authors:  W T Hermens; G M Willems; K M Nijssen; M L Simoons
Journal:  Lancet       Date:  1992-11-21       Impact factor: 79.321

2.  Mean transit time for the assessment of myocardial perfusion by videodensitometry.

Authors:  N H Pijls; G J Uijen; A Hoevelaken; T Arts; W R Aengevaeren; H S Bos; J H Fast; K L van Leeuwen; T van der Werf
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

3.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

4.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

5.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

6.  Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels.

Authors:  A van der Laarse; W T Hermens; L Hollaar; M Jol; G M Willems; H E Lemmers; A H Liem; J H Souverijn; J H Oudhof; J de Hooge
Journal:  Am Heart J       Date:  1984-02       Impact factor: 4.749

7.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

8.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

9.  Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.

Authors:  F Zijlstra; M J de Boer; W P Beukema; A L Liem; S Reiffers; D Huysmans; J C Hoorntje; H Suryapranata; M L Simoons
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

Review 10.  Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications.

Authors:  S Iliceto; V Marangelli; A Marchese; A Amico; L Galiuto; P Rizzon
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

View more
  1 in total

Review 1.  Reperfusing the myocardium - a damocles Sword.

Authors:  V K Shah; K K Shalia
Journal:  Indian Heart J       Date:  2017-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.